From the Journals

Adding vasopressin in distributive shock may cut AF risk


 

FROM JAMA


Mortality data were less consistent, they said.

Pooled data showed administration of vasopressin along with catecholamines was associated an 11% relative reduction in mortality. In absolute terms, 45 lives would be saved for every 1,000 patients receiving vasopressin, they noted.

However, the mortality findings were different when the analysis was limited to the two studies with low risk of bias. That analysis yielded a relative risk of 0.96 and was not statistically significant.

Studies show patients with distributive shock have a relative vasopressin deficiency, providing a theoretical basis for vasopressin administration as part of care, investigators said.

Pages

Recommended Reading

Late-Breaking Science preview: Sunday, Nov. 12
MDedge Hematology and Oncology
Direct oral anticoagulants okay during AF device placement
MDedge Hematology and Oncology
VIDEO: Anticoagulant underprescribing common, jeopardizing atrial fib patients
MDedge Hematology and Oncology
Surgical LAA occlusion tops anticoagulation for AF thromboprotection
MDedge Hematology and Oncology
LAA occlusion boosts anticoagulants’ protection
MDedge Hematology and Oncology
Beware of polypharmacy in patients taking warfarin
MDedge Hematology and Oncology
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
MDedge Hematology and Oncology
MDedge Daily News: Time to let more pregnant women into drug trials?
MDedge Hematology and Oncology
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Hematology and Oncology
First reversal agent for apixaban and rivaroxaban gets fast-track approval
MDedge Hematology and Oncology